News

New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, ...
A study led by Cancer Center at Illinois (CCIL) member Jason Ridlon, associate professor of animal sciences in the College of ...
Even if there are problems with the function, the kidneys do not have any special symptoms, making it difficult to recognize ...
This systematic review summarizes the literature examining the possible clinical benefits of EDTA chelation therapy in patients with preexistent cardiovascular disease. This is the largest review to ...
Molecules in blood and urine may reveal how much energy a person consumes from ultraprocessed foods, a key step to understanding the impact of the products that make up nearly 60% of the American ...
Their abstract, “Targeted Multiplexed Virus-Like Particles (MVPs) Enable Robust In Vivo Hematopoietic Stem Cell (HSC) Engineering,” is one of several the team presented at the annual meeting of the ...
He remains symptom-free. The treatment is now approved for more patients. “Patients with metastatic prostate cancer typically receive hormonal therapy as a first treatment,” says Memorial Sloan ...
A doctor speaks to the common causes for oily pee, and when to seek medical attention. Normal urine color can vary, from clear to pale yellow. However, certain health issues can influence its ...
That enzyme is required to convert ammonia, a byproduct of metabolism, to urea, a waste product released in urine. Without treatment ... to be a successful gene therapy. What's stunning is ...
An infant in Philadelphia has been successfully treated with a customized Crispr gene-editing therapy for a rare and deadly disease, doctors reported Thursday—a breakthrough in the futuristic ...
A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing treatment made just for him, according to the doctors who treated him.
A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing treatment made just for him. Researchers described the case in a new ...